Biogen Inc. is a biotechnology company based in Cambridge, Massachusetts, that discovers, develops and markets medicines for serious neurological and neurodegenerative diseases. Its products include treatments for multiple sclerosis, spinal muscular atrophy and Alzheimer's disease, along with biosimilar medicines. The company serves patients and physicians through hospitals, clinics and specialty pharmacies, and it also works with partners on research and development programmes in neuroscience.
On this site Biogen Inc. appears as a stock on the London Stock Exchange (UK), code 0R1B, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #173 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
91/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average26.3%
From 52-week high0.0%
MomentumStrong
91/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return25.4%
6-month return40.1%
12-month, skipping last month51.4%
Stability (higher is calmer)Strong
74/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)31.3%
Worst drawdown, 1 year (smaller is calmer)-13.8%
LiquidityWeak
35/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.16M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 138.07 – 255.00Daily closes, split-adjusted
Signals
50-day average225.30
200-day average200.23
Golden/death cross (60d)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)9.08
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
242.7
Bullish
EMA 10
243.8
Bullish
SMA 20
233.7
Bullish
EMA 20
237.0
Bullish
SMA 50
225.3
Bullish
EMA 50
226.7
Bullish
SMA 100
214.6
Bullish
EMA 100
216.5
Bullish
SMA 200
200.2
Bullish
EMA 200
202.3
Bullish
Oscillators (daily)
RSI (14)
70.57
Bearish
MACD (12, 26)
7.81
Bullish
Momentum (12)
11.90
Bullish
Stochastic %K (14)
94.66
Bearish
Williams %R (14)
-5.34
Bearish
CCI (20)
140.7
Bearish
Pivot points (classic, last session)
S3
242.0
S2
245.0
S1
249.0
Pivot
252.0
R1
256.0
R2
259.0
R3
263.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
